More than 20 years of experience in the field of biosimilars resulted in more than 70 agreements with companies from 22 countries and more than 100 scientists trained in our lab.

Map showing ICGEB transfers in the field of biotherapeutic products

Agreements for the technologies transfer have been concluded with industrial partners located in Argentina, Brazil, China, Cuba, Egypt, India, Iran, Jordan, Pakistan, Russia, South Africa, Sri Lanka, Syria, Turkey, United Arab Emirates, Uruguay and Venezuela.